Allarity Therapeutics, Inc. (ALLR) Return on equity 2024–2025
Allarity Therapeutics, Inc. (ALLR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-114.3%FY2025 · since FY2024: -207.6% → -114.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -114.3% | +93.3 pp |
| FY2024 | -207.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ALLR financial trends
ALLR RevenueALLR Net incomeALLR Net marginALLR Gross profitALLR Gross marginALLR Operating incomeALLR Operating marginALLR Operating cash flowALLR Free cash flowALLR Capital expendituresALLR Stock buybacksALLR Dividends paidALLR Total assetsALLR Total liabilitiesALLR Shareholders’ equityALLR overview →